Randomized controlled trial investigating use of submucosal injection of EverLift™ in rates of complete resection of non-pedunculated 4-9 mm polyps.
Mike Tzuhen WeiChristine Y LouieYu ChenJennifer Y PanSusan Y QuanRobert WongRyanne BrownMelissa ClarkKristin JensenHubert LauShai FriedlandPublished in: International journal of colorectal disease (2022)
Submucosal injection of EverLift™ was non-inferior to CSP of 4-9 mm polyps without injection and increased time for resection as well as use of hemostatic clips to control acute bleeding. Our results suggest that polypectomy of 4-9 mm polyps can be safely performed without submucosal injection of EverLift™.